Research programme: extracorporeal anti-cytokine therapy - Advanced Biotherapy
Alternative Names: Extracorporeal anti-cytokine therapy research programme - Advanced BiotherapyLatest Information Update: 04 Nov 2003
At a glance
- Originator Advanced Biotherapy
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 04 Nov 2003 Discontinued for Autoimmune disorders in USA (Extracorporeal)
- 16 Feb 2001 New profile
- 16 Feb 2001 Investigation in Autoimmune disorders in USA (Extracorporeal)